SONOMA PHARMACEUTICALS, INC. Derivative Liability, Current
SONOMA PHARMACEUTICALS, INC. (SNOA) had Derivative Liability, Current of $0 as of 2016-03-31, per its 10-K filed 2016-06-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2016-06-21
- 2016-03-31: Derivative Liability, Current $0.00.
- 2015-12-31: Derivative Liability, Current $1.00K.
- 2015-09-30: Derivative Liability, Current $5.00K.
- 2015-06-30: Derivative Liability, Current $70.00K.
| Period end | Derivative Liability, Current |
|---|---|
| 2016-03-31 | $0.00 10-K · filed 2016-06-21 |
| 2015-12-31 | $1.00K 10-Q · filed 2016-02-16 |
| 2015-09-30 | $5.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $70.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $11.00K 10-K · filed 2016-06-21 |
| 2014-12-31 | $177.00K 10-Q · filed 2015-02-12 |
| 2014-09-30 | $856.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.70M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $3.17M 10-K · filed 2015-06-16 |
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 |
| 2012-09-30 | $1.55M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $1.16M 10-Q/A · filed 2012-08-31 |
| 2012-03-31 | $55.00K 10-K · filed 2013-06-25 |
| 2011-12-31 | $34.00K 10-Q · filed 2012-02-10 |
| 2011-09-30 | $119.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $241.00K 10-Q/A · filed 2011-08-09 |
| 2011-03-31 | $337.00K 10-K · filed 2012-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |